Security Check
Dr. Jin Wang

Dr. Jin Wang, MD, Ph.D.

Senior Consultant
Code: 110440000705824
MO (Medical Oncology) CST-BC (Comprehensive Systemic Therapy for Breast Cancer) Ctx / Chemo (Chemotherapy) TT (Targeted Therapy) ITT (Tumor Immunotherapy)
Experience20+ years
LanguagesEnglish | 中文
Typical turnaround3–5 business days
Second-opinion formatWritten review

Overview

Prof. Jin Wang is a Chief Physician, PhD Supervisor, and MD. She is a senior specialist in Medical Oncology (Breast Cancer) at Sun Yat-sen University Cancer Center (SYSUCC). A renowned national expert in systemic therapy for breast cancer, she is dedicated to comprehensive medical oncology, particularly leading the field in individualized precision medicine and novel drug clinical trials.

Board Certification
Breast Surgery
Clinical Focus
PMO (Precision Medical Oncology) | Anti-HER2 Targeted (Targeted Therapy Specialist) | DRM (Drug Resistance Management) | ABC / MBC (Advanced / Metastatic Breast Cancer) | Clinical Trials (Novel Oncology Drugs)
Approach
Guideline-driven + personalized
Best for
New diagnosis · Recurrence · Complex decisions
Clinical focus & conditions

1.Subtype-Specific Precision Oncology
Targeted systemic therapy for HER2+, Triple-negative, and HR+ molecular subtypes.
2.Advanced & Metastatic Disease Care
Comprehensive multi-line management of locally advanced and metastatic breast cancer.
3.Management of Special Pathologies
Intensive, individualized protocols for Inflammatory Breast Cancer (IBC).
4.Molecularly-Driven Treatment Plans
Evidence-based oncology focusing on biomarker-guided therapeutic strategies.

Education & training

MD,Ph.D. — Sun Yat-sen University of Medical Sciences
Training — MD Anderson Cancer Center (USA)

Hospital affiliations

Sun Yat-sen University Cancer Center

Honors & Research

Honors:
Titled as "Yangcheng Good Doctor" and "Lingnan Famous Doctor"; recipient of multiple national academic and research awards in oncology.
Academic Affiliations:
Member of the CSCO Breast Cancer Expert Committee; Member of the Breast Cancer Committee of the Guangdong Anti-Cancer Association.
Research:
PI for multiple National Natural Science Foundation and provincial projects. Published high-impact papers in journals such as JCO and The Lancet Oncology, with research interests in drug resistance mechanisms and clinical translation.

Is my case a fit for a second opinion?

A second opinion is often helpful if you have a new diagnosis multiple treatment options discordant pathology or imaging results  progression/recurrence or you want confirmation before starting therapy.
•Good fit: complex decisions uncertainty multiple lines of therapy clinical trial questions.
•Not a fit: emergencies (e.g. severe symptoms acute complications). Seek urgent local care.

Important note

This page is for educational and second-opinion purposes. It is not a substitute for emergency care or an in-person exam. If you have urgent symptoms, contact local emergency services.